These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16427384

  • 1. Congenital and acquired platelet disorders: current dilemmas and treatment strategies.
    White GC.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S37-41. PubMed ID: 16427384
    [Abstract] [Full Text] [Related]

  • 2. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y.
    Pathophysiol Haemost Thromb; 2002 Jan; 32 Suppl 1():37-40. PubMed ID: 12214146
    [Abstract] [Full Text] [Related]

  • 3. Use of recombinant factor VIIa in inherited platelet disorders.
    Kaleelrahman M, Minford A, Parapia LA.
    Br J Haematol; 2004 Apr; 125(1):95-6. PubMed ID: 15015980
    [No Abstract] [Full Text] [Related]

  • 4. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC, Di Minno G, d'Oiron R, Zotz R.
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [Abstract] [Full Text] [Related]

  • 5. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 6. The use of recombinant factor VIIa in children with inherited platelet function disorders.
    Almeida AM, Khair K, Hann I, Liesner R.
    Br J Haematol; 2003 May; 121(3):477-81. PubMed ID: 12716372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A, Bayhan G, Yalinkaya A, Yayla M.
    J Perinat Med; 2004 May; 32(5):456-8. PubMed ID: 15493726
    [Abstract] [Full Text] [Related]

  • 10. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
    Clemetson KJ, Clemetson JM.
    Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
    [Abstract] [Full Text] [Related]

  • 11. Survival and function of transfused platelets. Studies in two patients with congenital deficiencies of platelet membrane glycoproteins.
    Cesar JM, Vecino AM.
    Platelets; 2009 May; 20(3):158-62. PubMed ID: 19437332
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
    Poon MC.
    Vasc Health Risk Manag; 2007 May; 3(5):655-64. PubMed ID: 18078017
    [Abstract] [Full Text] [Related]

  • 14. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
    Ozelo MC, Svirin P, Larina L.
    Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

  • 17. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
    Poon MC, d'Oiron R, Hann I, Négrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kühne A, Petrini P, Fressinaud E, Morfini M, Tengborn L, Marquès-Verdier A, Musso R, Devecioglu O, Houston DS, Lethagen S, Van Geet C, von Depka M, Berger C, Beurrier P, Britton HA, Gerrits W, Guthner C, Kuhle S, Lorenzo JJ, Makris PE, Nohe N, Paugy P, Pautard B, Torchet MF, Trillot N, Vicariot M, Wilde J, Winter M, Chambost H, Ingerslev J, Peters M, Strauss G.
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):21-5. PubMed ID: 11735106
    [Abstract] [Full Text] [Related]

  • 18. [Constitutional thrombopathies: from the clinical description of rare diseases (Glanzmann thrombasthenia and Bernard-Soulier syndrome) to the development of new antithrombotic agents].
    Caen J, Bellucci S.
    Bull Acad Natl Med; 1998 Oct; 182(7):1493-502; discussion 1502-3. PubMed ID: 9916343
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Congenital disorders associated with platelet dysfunctions.
    Nurden P, Nurden AT.
    Thromb Haemost; 2008 Feb; 99(2):253-63. PubMed ID: 18278172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.